• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SRp30c蛋白与隐蔽性5'剪接位点对凋亡调节因子Bcl-x可变剪接的拮抗作用

Antagonistic effects of the SRp30c protein and cryptic 5' splice sites on the alternative splicing of the apoptotic regulator Bcl-x.

作者信息

Cloutier Philippe, Toutant Johanne, Shkreta Lulzim, Goekjian Serge, Revil Timothée, Chabot Benoit

机构信息

RNA/RNP Group, Département de Microbiologie et d'Infectiologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Québec, Canada.

出版信息

J Biol Chem. 2008 Aug 1;283(31):21315-24. doi: 10.1074/jbc.M800353200. Epub 2008 Jun 5.

DOI:10.1074/jbc.M800353200
PMID:18534987
Abstract

Alternative 5' splice site selection allows Bcl-x to produce two isoforms with opposite effects on apoptosis. The pro-apoptotic Bcl-x(S) variant is up-regulated by ceramide and down-regulated by protein kinase C through specific cis-acting exonic elements, one of which is bound by SAP155. Splicing to the Bcl-x(S) 5' splice site is also enforced by heterogeneous nuclear ribonucleoprotein (hnRNP) F/H proteins and by Sam68 in cooperation with hnRNP A1. Here, we have characterized exon elements that influence splicing to the 5' splice site of the anti-apoptotic Bcl-x(L) isoform. Within a 86-nucleotide region (B3) located immediately upstream of the Bcl-x(L) donor site we have identified two elements (ML2 and AM2) that stimulate splicing to the Bcl-x(L) 5' splice site. SRp30c binds to these elements and can shift splicing to the 5' splice site of Bcl-x(L) in an ML2/AM2-dependent manner in vitro and in vivo. The B3 region also contains an element that represses the use of Bcl-x(L). This element is bound by U1 small nuclear ribonucleoprotein and contains two 5' splice sites that can be used when the Bcl-x(L) 5' splice site is mutated or the ML2/AM2 elements are deleted. Conversely, mutating the cryptic 5' splice sites stimulates splicing to the Bcl-x(L) site. Thus, SRp30c stimulates splicing to the downstream 5' splice site of Bcl-x(L), thereby attenuating the repressive effect of upstream U1 snRNP binding sites.

摘要

可变的5'剪接位点选择使得Bcl-x能够产生两种对细胞凋亡具有相反作用的异构体。促凋亡的Bcl-x(S)变体受到神经酰胺的上调,并通过特定的顺式作用外显子元件受到蛋白激酶C的下调,其中一个元件与SAP155结合。剪接至Bcl-x(S)的5'剪接位点也受到不均一核核糖核蛋白(hnRNP) F/H蛋白以及Sam68与hnRNP A1协同作用的促进。在此,我们鉴定了影响抗凋亡Bcl-x(L)异构体5'剪接位点剪接的外显子元件。在紧邻Bcl-x(L)供体位点上游的一个86个核苷酸的区域(B3)内,我们鉴定出两个刺激剪接至Bcl-x(L) 5'剪接位点的元件(ML2和AM2)。SRp30c与这些元件结合,并能在体外和体内以ML2/AM2依赖的方式将剪接转移至Bcl-x(L)的5'剪接位点。B3区域还包含一个抑制Bcl-x(L)使用的元件。该元件与U1小核核糖核蛋白结合,并包含两个5'剪接位点,当Bcl-x(L)的5'剪接位点发生突变或ML2/AM2元件被删除时可以使用。相反,突变隐蔽的5'剪接位点会刺激剪接至Bcl-x(L)位点。因此,SRp30c刺激剪接至Bcl-x(L)下游的5'剪接位点,从而减弱上游U1 snRNP结合位点的抑制作用。

相似文献

1
Antagonistic effects of the SRp30c protein and cryptic 5' splice sites on the alternative splicing of the apoptotic regulator Bcl-x.SRp30c蛋白与隐蔽性5'剪接位点对凋亡调节因子Bcl-x可变剪接的拮抗作用
J Biol Chem. 2008 Aug 1;283(31):21315-24. doi: 10.1074/jbc.M800353200. Epub 2008 Jun 5.
2
Selection of alternative 5' splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1.可变5'剪接位点的选择:U1 snRNP的作用以及SF2/ASF和hnRNP A1拮抗作用的模型
Mol Cell Biol. 2000 Nov;20(22):8303-18. doi: 10.1128/MCB.20.22.8303-8318.2000.
3
Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x.不均一核核糖核蛋白F/H可调节凋亡介质Bcl-x的可变剪接。
J Biol Chem. 2005 Jun 17;280(24):22641-50. doi: 10.1074/jbc.M501070200. Epub 2005 Apr 18.
4
The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x.RNA结合蛋白Sam68调节Bcl-x的可变剪接。
J Cell Biol. 2007 Mar 26;176(7):929-39. doi: 10.1083/jcb.200701005. Epub 2007 Mar 19.
5
SRp30c is a repressor of 3' splice site utilization.SRp30c是3'剪接位点利用的阻遏物。
Mol Cell Biol. 2002 Jun;22(12):4001-10. doi: 10.1128/MCB.22.12.4001-4010.2002.
6
Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection.新型剪接因子RBM25调节Bcl-x前体mRNA 5'剪接位点的选择。
Mol Cell Biol. 2008 Oct;28(19):5924-36. doi: 10.1128/MCB.00560-08. Epub 2008 Jul 28.
7
Regulation of BCL-X splicing reveals a role for the polypyrimidine tract binding protein (PTBP1/hnRNP I) in alternative 5' splice site selection.BCL-X剪接的调控揭示了多嘧啶序列结合蛋白(PTBP1/hnRNP I)在可变5'剪接位点选择中的作用。
Nucleic Acids Res. 2014 Oct 29;42(19):12070-81. doi: 10.1093/nar/gku922. Epub 2014 Oct 7.
8
An intron element modulating 5' splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1.一个在内含子核糖核蛋白A1前体信使核糖核酸中调节5'剪接位点选择的内含子元件与核糖核蛋白A1相互作用。
Mol Cell Biol. 1997 Apr;17(4):1776-86. doi: 10.1128/MCB.17.4.1776.
9
hnRNP I/PTB can antagonize the splicing repressor activity of SRp30c.异质性核糖核蛋白I/多嘧啶结合蛋白可拮抗SRp30c的剪接抑制活性。
RNA. 2007 Aug;13(8):1287-300. doi: 10.1261/rna.403607. Epub 2007 Jun 4.
10
SAP155 Binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5' splice site selection of Bcl-x pre-mRNA.SAP155与神经酰胺反应性RNA顺式元件1结合,并调节Bcl-x前体mRNA的可变5'剪接位点选择。
FASEB J. 2006 Aug;20(10):1680-2. doi: 10.1096/fj.05-5021fje. Epub 2006 Jun 21.

引用本文的文献

1
Repurposing alternative splicing events as potential targets for the design of diagnostic and therapeutic tools in PCa.将可变剪接事件重新用作前列腺癌诊断和治疗工具设计的潜在靶点。
Front Oncol. 2025 Mar 21;15:1520985. doi: 10.3389/fonc.2025.1520985. eCollection 2025.
2
Intronic RNA secondary structural information captured for the human pre-mRNA.为人类前体信使核糖核酸捕获的内含子RNA二级结构信息。
NAR Genom Bioinform. 2024 Oct 24;6(4):lqae143. doi: 10.1093/nargab/lqae143. eCollection 2024 Sep.
3
Alternative splicing of BCL-x is controlled by RBM25 binding to a G-quadruplex in BCL-x pre-mRNA.
BCL-x 的可变剪接受 RBM25 与 BCL-x 前体 mRNA 中 G-四链体的结合所控制。
Nucleic Acids Res. 2023 Nov 10;51(20):11239-11257. doi: 10.1093/nar/gkad772.
4
RNA splicing dysregulation and the hallmarks of cancer.RNA 剪接失调与癌症的特征。
Nat Rev Cancer. 2023 Mar;23(3):135-155. doi: 10.1038/s41568-022-00541-7. Epub 2023 Jan 10.
5
Knowledge mapping of alternative splicing of cancer from 2012 to 2021: A bibliometric analysis.2012年至2021年癌症可变剪接的知识图谱:一项文献计量分析。
Front Oncol. 2022 Dec 14;12:1068805. doi: 10.3389/fonc.2022.1068805. eCollection 2022.
6
Profiling disease-selective drug targets: From proteomics to ligandomics.疾病选择性药物靶点分析:从蛋白质组学到配体组学。
Drug Discov Today. 2023 Mar;28(3):103430. doi: 10.1016/j.drudis.2022.103430. Epub 2022 Nov 4.
7
Identification of an mRNA isoform switch for HNRNPA1 in breast cancers.鉴定乳腺癌中 HNRNPA1 的 mRNA 异构体转换。
Sci Rep. 2021 Dec 27;11(1):24444. doi: 10.1038/s41598-021-04007-y.
8
miRNA-Based Regulation of Alternative RNA Splicing in Metazoans.真核生物中基于 miRNA 的可变剪接调控。
Int J Mol Sci. 2021 Oct 27;22(21):11618. doi: 10.3390/ijms222111618.
9
The role of alternative splicing in human cancer progression.可变剪接在人类癌症进展中的作用。
Am J Cancer Res. 2021 Oct 15;11(10):4642-4667. eCollection 2021.
10
A spotter's guide to SNPtic exons: The common splice variants underlying some SNP-phenotype correlations.SNPtic 外显子观察指南:一些 SNP 表型相关性背后的常见剪接变体。
Mol Genet Genomic Med. 2022 Jan;10(1):e1840. doi: 10.1002/mgg3.1840. Epub 2021 Oct 28.